期刊
CANCER JOURNAL
卷 18, 期 1, 页码 26-31出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/PPO.0b013e318244d7c8
关键词
Glioblastoma; response assessment; neuro-oncology criteria
类别
资金
- National Cancer Institute/National Institutes of Health [1PO1 CA168940-01]
Glioblastoma is the most common primary malignant brain tumor; standard initial treatment includes a combination of radiation and temozolomide, and treatment at recurrence often includes the use of antiangiogenic agents. Characterization of tumor at initial diagnosis, assessment of response, and ability to distinguish viable tumor from treatment effects are ongoing challenges in neuroimaging. Progress has been made with the new Response Assessment in Neuro-Oncology criteria, and new imaging modalities and combinations continue to be evaluated to further improve our ability to characterize glioblastomas at all points during their disease course.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据